HX044,FIH Study in Patients with Advanced Solid Tumor Malignancies
Clinical trial NCT06649708 · RECRUITING
Trial details
- NCT number
- NCT06649708
- Sponsor
- Hanx Biopharmaceuticals (Wuhan) Co., Ltd.
- Status
- RECRUITING
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2024-12-30
- Primary completion
- 2025-10-31
- Enrollment
- 100
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.